UTAH MEDICAL PRODUCTS INC (UTMD) › Capital ExpendituresUTAH MEDICAL PRODUCTS INC (UTMD) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $466.0K2010: $1.53M2011: $247.0K2012: $254.0K2013: $339.0K2014: $1.11M2015: $176.0K2016: $3.29M2017: $1.60M2018: $402.0K2019: $540.0K2020: $860.0K2021: $552.0K2022: $809.0K2023: $639.0K2024: $230.0K2025: $371.0K$371.0K2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$371.0K+61.3%2024$230.0K-64.0%2023$639.0K-21.0%2022$809.0K+46.6%2021$552.0K-35.8%2020$860.0K+59.3%2019$540.0K+34.3%2018$402.0K-74.8%2017$1.60M-51.5%2016$3.29M+1771.0%2015$176.0K-84.1%2014$1.11M+227.4%2013$339.0K+33.5%2012$254.0K+2.8%2011$247.0K-83.9%2010$1.53M+228.8%2009$466.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share